[
  {
    "question": "TBI and AED as a prophylaxis:",
    "option_a": "Decrease early and late SZ",
    "option_b": "Decrease early SZ",
    "option_c": "Decrease late SZ",
    "option_d": "Don't decrease frequency but decrease severity of seizure.",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Traumatic brain injury (TBI) can provoke seizures by injuring neuronal tissue. Seizure prophylaxis in the context of TBI is used to prevent early post\u2010traumatic seizures (those that occur within 7 days) but has not been shown to reduce the incidence of late (post\u2010traumatic) seizures. After TBI, damage to neuronal membranes and subsequent biochemical cascade (including excitotoxicity and ionic imbalances) predisposes the brain to early seizures. The early seizures are thought to be due to acute neuronal irritability, which can be mitigated by AEDs. However, later seizures (post-traumatic epilepsy) result from longer-term structural reorganization and gliosis that AED prophylaxis does not prevent. Clinically, patients with TBI can have seizures in the immediate period (first 7 days) after injury. Prophylactic AEDs (often phenytoin or levetiracetam) are used in the acute setting to decrease the risk of early seizures, though they do not reduce the risk of developing epilepsy later on. Diagnosis is based on the clinical history of TBI and subsequent seizure activity. EEG may be used if seizures are suspected, and neuroimaging (CT/MRI) assists in evaluating the extent of injury. Differential diagnoses include post-traumatic intracranial hemorrhage and non-epileptic events such as syncope. Current guidelines recommend short-term AED prophylaxis for 7 days after TBI to prevent early seizures. There is no evidence that prolonged AED use prevents late seizures. For special populations like pregnant or lactating women, careful AED selection is important; if needed, agents with lower teratogenic potential should be considered and doses adjusted according to physiological changes. Option A is incorrect because prophylaxis does not reduce both early and late seizures. Option B is correct, as AED prophylaxis in TBI has been shown to decrease early seizures. Option C is incorrect because late seizures are not prevented by short-term AED prophylaxis. Option D is incorrect because the purpose of AED prophylaxis is not merely to reduce seizure severity but specifically to lower the incidence of early seizures. 1) Prophylactic AEDs in TBI are only effective in reducing early post-traumatic seizures. 2) Long-term prophylaxis does not prevent the development of post-traumatic epilepsy. 3) Careful risk-benefit assessment is required, particularly in special populations. Recent studies continue to support the use of AED prophylaxis only to reduce early seizures after TBI. Major guidelines (e.g., Brain Trauma Foundation) emphasize that while early prophylaxis can reduce immediate seizure risk, it does not alter long-term epilepsy risk.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "Pregnant lady post tumor resection on OCP and known to have seizure which of the following AED would be least likely to interact with her oral contraceptive pills?",
    "option_a": "Levetiracetam",
    "option_b": "Carbamazepine",
    "option_c": "Lamotrigine",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "In women of childbearing age, particularly those using oral contraceptive pills (OCPs), drug interactions are a key consideration when choosing an antiepileptic drug (AED). Enzyme-inducing AEDs can accelerate the metabolism of OCPs, reducing their effectiveness. Enzyme-inducing AEDs like carbamazepine increase the activity of cytochrome P450 enzymes, leading to faster metabolism of estrogen and progesterone. Although lamotrigine is not a classic CYP inducer, it undergoes glucuronidation which can be accelerated by OCPs, reducing its own levels. Levetiracetam, on the other hand, is not metabolized by the liver enzymes responsible for these interactions and therefore has minimal effect on OCP levels. For a pregnant patient or a woman planning pregnancy, it is crucial to use an AED that does not compromise the effectiveness of OCPs, to avoid unplanned pregnancy and potential teratogenic risks from AED exposure in early pregnancy. Reviewing the medication profile and understanding the metabolic pathways of both AEDs and OCPs is necessary. Therapeutic drug monitoring may be indicated for AEDs like lamotrigine when used concurrently with OCPs. First-line management for women on OCPs who require AED therapy often favors levetiracetam due to its minimal interaction profile. When lamotrigine is used, monitoring serum levels and adjusting doses may be necessary. In pregnant or lactating women, levetiracetam is also preferred because it has a favorable teratogenic profile and does not interfere with OCP efficacy. Option A (Levetiracetam) is correct because it does not induce liver enzymes that affect OCPs. Option B (Carbamazepine) is incorrect because it is a potent enzyme inducer that decreases OCP efficacy. Option C (Lamotrigine) is also less ideal as it has known interactions with OCPs, leading to altered ASM levels. Option D is not applicable. 1) Avoid enzyme-inducing AEDs in women of childbearing potential to minimize interactions with OCPs. 2) Levetiracetam is often the AED of choice in these cases. 3) Always consider the potential for drug interactions when managing epilepsy in pregnant women. Recent guidelines from the International League Against Epilepsy (ILAE) and other bodies advocate the use of AEDs with minimal drug interactions, such as levetiracetam, in women of reproductive age to ensure both seizure control and effective contraception.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "Scenario of patient was on Valproic acid and discovered to be drowsy what do you need to check?",
    "option_a": "Ammonia level",
    "option_b": "Liver enzyme",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Valproic acid is associated with several adverse effects including hepatotoxicity and hyperammonemia. Drowsiness in a patient on valproate may indicate hyperammonemia, a known side effect even in the absence of liver enzyme abnormalities. Valproic acid interferes with the urea cycle by inhibiting key enzymes, resulting in the accumulation of ammonia in the blood. This hyperammonemia can lead to encephalopathy, which is often manifested as drowsiness and cognitive impairment rather than overt liver dysfunction. A patient on valproic acid presenting with drowsiness should raise suspicion for hyperammonemic encephalopathy rather than solely attributing the symptoms to liver toxicity. Thus, checking an ammonia level can help confirm the diagnosis. In a patient with signs of central nervous system depression on valproate, the evaluation should include measurement of serum ammonia as well as liver function tests and valproate serum levels. Differential diagnoses include hepatic encephalopathy, drug overdose, and intrinsic metabolic disturbances unrelated to valproate. Management of hyperammonemia involves reducing or holding valproate dosage, possibly administering L-carnitine, and supportive care. In pregnancy and lactation, careful management of valproate is essential due to its teratogenic potential and the need for vigilant monitoring of associated side effects. Option A (Ammonia level) is the correct choice since hyperammonemia is a recognized cause of drowsiness in patients on valproate. Option B (Liver enzyme testing) is less immediately helpful if the main concern is hyperammonemia, especially as liver enzymes may remain normal despite elevated ammonia levels. Options C and D are not provided, making Option A the most appropriate. 1) Valproate can cause hyperammonemic encephalopathy, which may present as drowsiness even when liver enzymes are normal. 2) Always check ammonia levels in patients on valproate with signs of encephalopathy. 3) Timely recognition of hyperammonemia can prevent progression to severe toxicity. Recent research reinforces the dissociation between liver enzyme abnormalities and hyperammonemia in patients on valproate. Clinicians are advised to monitor ammonia levels when central nervous system side effects occur, even if liver function tests are unremarkable.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "6-year-old with staring episode, picture of absence epilepsy EEG done showed 3 HZ. Mother was concern of slightly developmentally delayed, her skin is normal, history of one of the parents have absence seizure in adulthood, which comorbidities can be associated with in the future?",
    "option_a": "ADHD",
    "option_b": "Cardiac rhabdomyoma",
    "option_c": "Renal angiomyolipoma",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Childhood absence epilepsy is an idiopathic generalized epilepsy syndrome characterized by brief staring spells (absences) and a classic EEG finding of 3 Hz spike-and-wave discharges. It is frequently associated with neurodevelopmental comorbidities, such as attention deficit hyperactivity disorder (ADHD). The underlying mechanism involves abnormalities in thalamocortical circuits, leading to the abrupt and transient impairment of consciousness. This circuit dysfunction is not only responsible for the seizure activity but is also believed to influence attentional processes, contributing to the development of ADHD. Children with absence seizures often present with multiple daily episodes of staring and may have accompanying learning difficulties or behavioral issues. The association with ADHD is well-documented, and these children may require evaluation and treatment for attentional deficits. Diagnosis is based on clinical history and EEG findings showing a 3 Hz spike-and-wave pattern. Differential diagnoses include focal seizures causing impaired awareness, daydreaming, or other forms of non-epileptic paroxysmal events. Differentiation is made via EEG, clinical history, and sometimes neuropsychological testing. First-line treatment for absence seizures is ethosuximide, especially when seizures are isolated. Valproate is an alternative, particularly if there are concomitant generalized tonic-clonic seizures. In patients with comorbid ADHD, careful management is required; stimulant medications (e.g., methylphenidate) can be used, but close monitoring for seizure exacerbation is essential. These treatment principles remain similar regardless of pregnancy or lactation, although in older children who might become reproductive, later transition to AEDs with lower teratogenic risk may be considered. Option A (ADHD) is the correct answer as it is a well-recognized comorbidity associated with childhood absence epilepsy. Option B (Cardiac rhabdomyoma) and Option C (Renal angiomyolipoma) are typically associated with tuberous sclerosis complex, which also has characteristic skin findings that are absent in this case. 1) ADHD is a common comorbidity in childhood absence epilepsy and should be screened for in affected children. 2) Ethosuximide remains the first-line treatment for absence seizures. 3) A normal skin examination helps differentiate idiopathic absence epilepsy from syndromes like tuberous sclerosis. Recent studies have reinforced the link between childhood absence epilepsy and ADHD, highlighting the need for comprehensive neuropsychological evaluation. Updated guidelines recommend a multidisciplinary approach to manage both seizures and associated attentional deficits.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "True regarding absence seizure:",
    "option_a": "Carbamazepine effective",
    "option_b": "Ethosuximide cause status in absence",
    "option_c": "Pathophysiology related to T calcium channel.",
    "option_d": "is missing.",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "Absence seizures are brief, generalized epileptic events characterized by sudden onset and transient lapses in consciousness. They are common in children and typically do not involve motor convulsions. The underlying mechanism in absence seizures involves abnormal oscillatory activity in the thalamocortical network. A key player is the low\u2010threshold T-type calcium channel in thalamic neurons, which contributes to the generation of the classic 3 Hz spike-and-wave discharges seen on EEG. Clinically, absence seizures present as short episodes of blank staring and subtle motor signs, often mistaken for daydreaming or inattention. These events are usually very brief and the patient immediately resumes activity afterward without postictal confusion. Diagnosis is based on a detailed clinical history and EEG findings. The hallmark is a generalized 3 Hz spike-and-wave pattern on EEG. Differential diagnoses include complex partial seizures, attention deficit disorders, and other non-epileptic paroxysmal events. First-line treatment is ethosuximide, especially in children with pure absence epilepsy, due to its effectiveness and relatively favorable side effect profile. Valproic acid is an alternative, particularly when other seizure types coexist. Carbamazepine is contraindicated as it may worsen seizure frequency. In pregnant patients, valproate is generally avoided due to teratogenicity; ethosuximide is preferred with careful monitoring. Option A is incorrect because carbamazepine can exacerbate absence seizures rather than treat them. Option B is also incorrect since ethosuximide is used as a treatment and does not induce status epilepticus; in fact, it is the drug of choice. Option C is correct as it rightly identifies the role of T-type calcium channels in the pathogenesis of absence seizures. Option D is missing. 1) Absence seizures are typically very brief and often mistaken for inattention. 2) The EEG hallmark of absence seizures is a 3 Hz spike-and-wave pattern. Recent research continues to support the role of T-type calcium channels in absence seizures, reinforcing the rationale for using ethosuximide as first-line therapy. Updated treatment guidelines emphasize avoiding drugs like carbamazepine that may worsen these seizures.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "Most common cause of sudden unexpected death in epilepsy is:",
    "option_a": "Uncontrolled seizure",
    "option_b": "Status epilepticus",
    "option_c": "Drowning",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Sudden unexpected death in epilepsy (SUDEP) refers to the sudden, unexpected, and non-traumatic death of an individual with epilepsy, with no clear structural or toxicological cause identified at autopsy. The pathophysiology of SUDEP is not fully understood but is thought to involve cardiorespiratory dysfunction triggered by a generalized tonic-clonic seizure. Autonomic instability during or shortly after a seizure can lead to fatal arrhythmias or respiratory arrest. Patients with frequent, uncontrolled generalized tonic-clonic seizures are at a higher risk for SUDEP. These events often occur during sleep and when the patient is alone, making early detection and aggressive seizure management critical. There is no specific diagnostic test for SUDEP; it is a diagnosis of exclusion made after ruling out other causes of death. Differential considerations include status epilepticus, accidental injuries, or metabolic disturbances. The cornerstone of preventing SUDEP is optimal seizure control. First-line strategies involve a comprehensive review and optimization of antiepileptic drug regimens. In patients of childbearing potential or pregnant women, careful balancing of seizure control with the teratogenic risks of certain medications is crucial. Counseling on nocturnal supervision and lifestyle modifications is also recommended. Option A is correct because uncontrolled seizures\u2014 particularly frequent generalized tonic-clonic seizures\u2014are the most significant risk factor for SUDEP. Option B, status epilepticus, is less commonly implicated specifically in SUDEP. Option C, drowning, while a risk in some patients, is an accidental cause rather than the intrinsic SUDEP phenomenon. 1) The frequency of generalized tonic-clonic seizures is a strong predictor of SUDEP risk. 2) Maximizing seizure control is the best strategy to mitigate the risk of SUDEP. Recent studies continue to affirm that improved control of generalized tonic-clonic seizures can reduce SUDEP risk. Guidelines stress comprehensive management strategies, including medication optimization and patient education, to prevent these tragic events.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "70-year-old man with history of obesity, hypertension, hypercholesterolemia, nephrolithiasis and atrial fibrillation is evaluated for recent onset seizure. An MRI of the head shows an old right frontal ischemic stroke. Current medications include enalapril, simvastatin and warfarin. Which of the following is the most appropriate drug for seizure treatment in his patient?",
    "option_a": "Gabapentin",
    "option_b": "Lamotrigine",
    "option_c": "Phenytoin",
    "option_d": "Topiramate",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Late-onset epilepsy in the elderly is often secondary to structural brain lesions, with cerebrovascular disease (such as ischemic stroke) being a common cause. Treatment in this population must account for comorbidities and polypharmacy. In this patient, an old right frontal ischemic stroke acts as a structural lesion leading to the development of an epileptogenic focus. The resultant neuronal scarring and disruption in cortical inhibitory circuits predispose to focal seizure activity. Elderly patients with vascular risk factors presenting with new-onset seizures often have underlying cerebrovascular disease. It is essential to consider concomitant medications (e.g., warfarin) to avoid drug interactions and further complications. Diagnosis involves neuroimaging (MRI) to identify structural causes such as old strokes and EEG to document seizure activity. Differentials include metabolic disturbances, transient ischemic attacks, and syncope. Lamotrigine is recommended as a first-line agent for focal seizures in the elderly due to its favorable efficacy, tolerability, and minimal drug interactions, especially important in patients taking anticoagulants like warfarin. Gabapentin is an alternative, though lamotrigine is often preferred for its broader antiepileptic profile. In pregnant patients, lamotrigine is used with close monitoring due to variable serum levels during pregnancy, and it is considered relatively safe during lactation. Option A (Gabapentin) is a reasonable choice but may be less efficacious in some cases of focal epilepsy compared to lamotrigine. Option B (Lamotrigine) is the best choice given its efficacy, tolerability, and low interaction profile. Option C (Phenytoin) is less ideal because of its narrow therapeutic index and significant interactions, especially with warfarin. Option D (Topiramate) can cause cognitive impairment and is generally less favored in the elderly. 1) Post-stroke epilepsy is a common cause of new-onset seizures in the elderly. 2) Lamotrigine is often first-line in older adults due to its safety profile and fewer drug interactions. Recent guideline updates advocate for the use of lamotrigine or levetiracetam as first-line treatments for focal seizures in the elderly, reinforcing the benefits of lamotrigine in patients with comorbidities and on polypharmacy regimens.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "26-year-old lady, present to emergency room with 4 tonic clonic seizure, lorazepam and phenytoin loading dose given. Seizure aborted. Neurology was consulted because patient remained unresponsive for 5 hours. The most appropriate next step is:",
    "option_a": "Give an additional 50 mg/kg IV phenytoin",
    "option_b": "Order continuous EEG",
    "option_c": "Leave the patient till she wakes up",
    "option_d": "LP",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "After the cessation of convulsive seizures, patients generally experience a postictal state characterized by transient cognitive impairment. However, prolonged unresponsiveness raises concern for nonconvulsive status epilepticus (NCSE), which is seizure activity without overt convulsive manifestations. NCSE occurs when seizure activity persists without the classic motor signs, leading to impaired consciousness. This can result from incomplete suppression of electrical seizure activity following the initial convulsive phase, and may be exacerbated by sedative effects of loading doses of drugs like phenytoin. In this 26-year-old woman, unresponsiveness for 5 hours post-seizure is atypical for a normal postictal state and suggests the possibility of ongoing epileptiform activity. Recognizing NCSE is critical as it requires prompt intervention to prevent further neuronal injury. The gold standard for diagnosing NCSE is continuous EEG monitoring. Differentials include drug-induced sedation, metabolic causes of decreased consciousness, or prolonged postictal states. A lumbar puncture, additional anticonvulsant dosing, or waiting passively are not appropriate without EEG confirmation. Once NCSE is confirmed by continuous EEG, treatment typically involves escalating antiepileptic therapy. In pregnant or lactating patients, drug selection must balance maternal and fetal safety against the risk of ongoing seizures, often favoring drugs with a more established safety profile in these populations. Option A (additional IV phenytoin) is inadvisable without EEG evidence of ongoing seizure activity. Option B (ordering continuous EEG) is the correct next step to evaluate for NCSE. Option C (waiting for the patient to wake up) may delay critical diagnosis and treatment if NCSE is present. Option D (lumbar puncture) is not indicated without signs suggesting infection or intracranial pathology beyond seizures. 1) Prolonged unresponsiveness post-seizure is a red flag for nonconvulsive status epilepticus. 2) Continuous EEG monitoring is the key diagnostic tool to detect NCSE. Recent research has underscored the importance of continuous EEG monitoring in patients with unexplained prolonged altered mental status post-seizure, with current guidelines advocating its use to promptly diagnose and manage NCSE.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "Vigabatrin side effect:",
    "option_a": "Irreversible visual loss",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Vigabatrin is an antiepileptic drug that functions as an irreversible inhibitor of GABA transaminase, thereby increasing brain GABA levels. It is used primarily in refractory partial seizures and infantile spasms. One of its most serious adverse effects is related to the visual system. Vigabatrin\u2019s retinal toxicity is believed to stem from the accumulation of GABA or related metabolites in the retina, leading to damage and death of retinal ganglion cells. The resulting dysfunction typically manifests as bilateral, concentric peripheral visual field defects that in many cases are irreversible. Studies have indicated that the toxicity is dose-dependent and cumulative over time. In practice, patients on vigabatrin may develop irreversible visual field constriction (often described as 'tunnel vision'). This adverse effect is of particular concern due to its permanent nature. Periodic ophthalmologic evaluation is recommended to detect early changes before irreversible loss occurs. The diagnosis of vigabatrin-induced visual toxicity relies on serial ophthalmologic examinations, including automated perimetry, fundoscopic examination, and sometimes optical coherence tomography (OCT). Differential diagnoses for visual field loss include glaucoma, optic neuropathies, or retinopathies of other etiologies, which are excluded based on clinical history and imaging. First-line management for patients requiring vigabatrin includes careful dose titration and regular ophthalmologic assessments (baseline and every 3-6 months) to monitor retinal function. If visual changes are detected, discontinuation or change of therapy should be considered. During pregnancy and lactation, the risks and benefits must be carefully weighed as vigabatrin is generally avoided due to potential teratogenicity and the irreversible nature of its adverse effects. Option A, 'Irreversible visual loss', is correct. Other options were not provided, but the key known adverse effect of vigabatrin is the permanent, bilateral concentric peripheral field loss. 1. Vigabatrin is associated with irreversible peripheral field defects; regular ophthalmologic monitoring is essential. 2. Patients should be counseled regarding the risk of permanent visual loss before initiating therapy. Recent reviews and guidelines continue to emphasize the risk of retinal toxicity with vigabatrin, supporting recommendations for regular visual field assessments. Ongoing research is evaluating mechanisms of toxicity and potential protective measures.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "28-year-old man with one year history of episodes of posturing of both arms, described by his wife as flexion of one arm and extension of the other arm, head turn, and facial grimacing, no loss of consciousness, occurs once a week and last less than 1 minute. Localization:",
    "option_a": "Cingulate",
    "option_b": "Supplementary motor area",
    "option_c": "Orbitofrontal",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "The patient\u2019s description of brief episodes with asymmetric posturing (one arm flexed and the other extended), head turning, and facial grimacing without loss of consciousness is characteristic of a focal motor seizure. The localization of such motor phenomena is most often attributed to regions of the frontal lobe responsible for planning and execution of movements. Seizures originating from the supplementary motor area (SMA) of the frontal lobe can produce bilateral or asymmetric tonic posturing with preserved awareness. The SMA is involved in the initiation and coordination of movement, and its abnormal hyperexcitability can generate motor phenomena that may appear complex but are relatively brief. Patients with SMA seizures typically experience brief motor events (lasting less than a minute) with preserved consciousness, as seen in this case. The clinical presentation may include unusual posturing, grimacing, and sometimes head turning, which are indicative of the localized cortical involvement in motor planning. The diagnostic workup includes a detailed history, video-EEG monitoring, and high-resolution MRI scans. Differential diagnoses include: (a) seizures originating from the primary motor cortex (Jacksonian seizures), which typically have a spreading pattern, and (b) seizures from the cingulate or orbitofrontal regions, which often exhibit additional affective or autonomic features. Video-EEG can help differentiate these based on the onset and propagation patterns of the electrical discharges. Management involves the initiation of appropriate antiepileptic drugs (AEDs) that cover focal seizures (such as levetiracetam, lamotrigine, or carbamazepine). In cases of drug-resistant seizures, surgical evaluation might be warranted. In pregnant or lactating patients, AED selection should consider teratogenic risks; for instance, lamotrigine and levetiracetam have more favorable profiles compared to others, with careful monitoring and supplemental folate in pregnancy. Option B, 'Supplementary motor area', is correct given the classic description of motor phenomena originating from this region. Option A (Cingulate) might be associated with affective and autonomic symptoms rather than the described motor posturing, and Option C (Orbitofrontal) would typically present with more behavioral and cognitive disturbances. 1. Focal motor seizures from the SMA are usually brief (<1 minute) and preserve consciousness. 2. Asymmetric tonic posturing (one limb flexing and the other extending) is a key localizing sign for SMA involvement. Contemporary research with advanced neuroimaging and video-EEG monitoring has reinforced the localization of specific motor seizure types to the SMA, allowing for more targeted treatment approaches and improved outcomes in refractory cases.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "Scenario of patient present to emergency room with status absence seizure. What of those medication can aggravate this condition?",
    "option_a": "Phenytoin",
    "option_b": "Topamax",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Status absence seizures are a prolonged form of absence epilepsy, characterized by continuous or frequently recurring typical brief staring spells. The management of absence seizures requires drugs that are effective in generalized epilepsies, such as ethosuximide or valproate. Absence seizures involve abnormal thalamocortical oscillatory rhythms, leading to the classic 3 Hz spike-and-wave pattern on EEG. Medications like phenytoin, which act on voltage-gated sodium channels, target focal and generalized tonic-clonic seizures but can exacerbate the abnormal oscillatory circuits in absence seizures. Patients present with episodes of staring and impaired responsiveness without convulsive activity, typically lasting seconds. In status absence, these episodes persist for an extended period. The inappropriate use of sodium channel blockers such as phenytoin can aggravate this condition by further destabilizing neuronal networks involved in maintaining normal thalamocortical rhythms. Diagnosis is primarily based on the characteristic EEG findings (3 Hz spike-and-wave discharges) and clinical history. Differential diagnoses include other types of generalized seizure disorders, psychogenic non-epileptic seizures, and metabolic encephalopathies, which can be differentiated based on EEG patterns and clinical context. First-line agents for typical absence seizures include ethosuximide and valproate. Ethosuximide is generally preferred when absence seizures occur in isolation, while valproate is selected if there are coexisting generalized tonic-clonic seizures. Phenytoin is contraindicated as it may worsen seizure activity. In pregnancy and lactation, the use of valproate is generally avoided due to high teratogenicity; ethosuximide or lamotrigine (with careful monitoring) may be considered, with folate supplementation being important. Option A, 'Phenytoin', is correct as it is known to aggravate absence seizures. In contrast, Topamax (topiramate) is not a typical aggravator of absence seizures and is sometimes used for other seizure types, though it is not a first-line treatment for absence epilepsy. 1. Avoid using sodium channel blockers like phenytoin in patients with absence epilepsy as they can worsen the condition. 2. Ethosuximide remains the first-line treatment for pure absence seizures. Current guidelines continue to support ethosuximide or valproate as first-line treatments for absence seizures, and emphasize the importance of avoiding drugs like phenytoin that can exacerbate thalamocortical dysrhythmia.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "33-year-old with history of generalized tonic clonic seizure with aura of a rising abdominal sensation. Most likely localization:",
    "option_a": "Temporal lobe epilepsy",
    "option_b": "Frontal lobe",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "The aura of a rising abdominal sensation, often described as an epigastric aura, is a classical feature of temporal lobe epilepsy, particularly involving the mesial temporal structures. This sensation serves as a warning sign of an impending seizure and is highly lateralizing. Temporal lobe epilepsy, especially when arising from mesial structures such as the hippocampus and amygdala, frequently produces visceral sensations due to the involvement of autonomic and limbic networks. The abnormal electrical discharge in these regions is perceived as a rising sensation in the abdomen, which may precede more widespread seizure activity culminating in a secondary generalized tonic-clonic seizure. The presence of an epigastric aura is a valuable clinical clue that points toward a temporal lobe origin of the seizure. Patients often describe this rising sensation as sudden and intense, sometimes accompanied by emotional disturbances or d\u00e9j\u00e0 vu. These features are typically absent in seizures originating from other cortical regions. The workup includes a detailed clinical history, video-EEG monitoring, and high-resolution MRI to identify structural lesions such as mesial temporal sclerosis. Differential diagnoses include seizures of frontal origin\u2014which tend to have a more abrupt onset and often lack a clear aura\u2014and insular seizures, which can produce unpleasant visceral sensations but are less common. A combination of semiology and imaging helps in accurate localization. Management typically involves first-line antiepileptic drugs (AEDs) such as carbamazepine, lamotrigine, or levetiracetam. In patients with drug-resistant temporal lobe epilepsy, surgical resection may be considered. Regarding pregnancy and lactation, AED selection should account for teratogenic risks; for example, carbamazepine and lamotrigine are generally preferred over highly teratogenic drugs (like valproate) with appropriate folate supplementation to reduce neural tube defect risks. Option A, 'Temporal lobe epilepsy', is correct as the rising abdominal sensation (epigastric aura) is classic for mesial temporal lobe involvement. Option B (Frontal lobe) is less likely because frontal lobe seizures typically present with motor phenomena or behavioral arrest rather than a visceral aura. 1. An epigastric aura is a hallmark of temporal lobe epilepsy and provides crucial localizing information. 2. Temporal lobe epilepsy is the most common form of focal epilepsy encountered in clinical practice. Recent studies and clinical guidelines continue to reinforce the diagnostic significance of auras in seizure localization. High-resolution MRI and EEG remain central to the evaluation, and the evolving understanding of mesial temporal sclerosis has spurred renewed interest in early surgical intervention for drug-resistant cases.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "Scenario of young child with seizure, hypotonia and cherry red spot. Enzyme affected:",
    "option_a": "Hexosaminidase A.",
    "option_b": "Glucocerebrosidase",
    "option_c": "Sphingolipidosis",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This question describes a young child with seizures, hypotonia, and a cherry red spot on the macula\u2014a classical presentation of Tay-Sachs disease, a lysosomal storage disorder. The key enzyme deficiency in Tay-Sachs is Hexosaminidase A, leading to the accumulation of GM2 ganglioside. In Tay-Sachs disease, mutations in the HEXA gene result in deficient activity of hexosaminidase A. This deficiency prevents the normal degradation of GM2 ganglioside, which then accumulates within neurons and leads to progressive neurodegeneration. The accumulation is particularly damaging in the central nervous system, leading to the clinical findings observed. Clinically, Tay-Sachs disease often presents in infancy with symptoms such as exaggerated startle response, seizures, hypotonia, and a characteristic cherry red spot on the retina. The cherry red spot appears due to lipid accumulation in the retinal ganglion cells, except in the fovea which remains relatively clear. Diagnosis is primarily established via enzyme assay demonstrating reduced hexosaminidase A activity. Genetic testing can confirm mutations in the HEXA gene. Differential diagnoses to consider include Niemann-Pick disease (which also presents with a cherry red spot but is typically associated with hepatosplenomegaly) and Gaucher disease (involving glucocerebrosidase deficiency without the cherry red spot). There is currently no cure for Tay-Sachs disease. Management is supportive and symptomatic, focusing on seizure control, nutritional support, and management of respiratory or gastrointestinal complications. Genetic counseling is essential for affected families. While no specific pregnancy or lactation guidelines apply directly to patients with Tay-Sachs (given its early and severe presentation), carrier screening and counseling are critical preventative measures. Option A (Hexosaminidase A) is correct. Option B (Glucocerebrosidase) refers to the enzyme deficient in Gaucher disease. Option C (Sphingolipidosis) is a broad category of disorders and not a specific enzyme deficiency; thus, it is not an appropriate answer. 1. A cherry red macular spot with seizures and hypotonia in infants is highly suggestive of Tay-Sachs disease. 2. Differentiating Tay-Sachs from Niemann-Pick is crucial; note that Niemann-Pick typically includes hepatosplenomegaly. 3. Genetic counseling is a cornerstone in managing families at risk. Recent research continues to focus on potential gene therapies and enzyme replacement strategies for lysosomal storage disorders, though as yet no definitive treatment for Tay-Sachs is available. Current management remains supportive, with ongoing studies aiming to modify disease progression.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "patient with seizure sometimes had febrile seizure, case of Dravet, what is correct:",
    "option_a": "Carbamazepine worsens the seizure.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Dravet syndrome (severe myoclonic epilepsy of infancy) is characterized by prolonged seizures often triggered by fever and a variety of seizure types. One of the critical aspects of managing Dravet syndrome is the avoidance of medications, such as carbamazepine, that can exacerbate seizure activity. Dravet syndrome typically results from mutations in the SCN1A gene, which encodes a sodium channel subunit. This mutation leads to dysfunctional sodium channel activity particularly in inhibitory neurons, predisposing to hyperexcitability. Sodium channel blockers like carbamazepine further impair channel function, worsening seizure control. Patients with Dravet syndrome often present with prolonged, refractory seizures beginning in the first year of life, frequently associated with fever. A history of simple febrile seizures can precede the development of more severe seizure types. The use of carbamazepine has been documented to aggravate the seizure frequency and severity in these patients. Diagnosis is based on clinical history, seizure semiology, and is confirmed by genetic testing for SCN1A mutations. EEG may show generalized or focal abnormalities. Differential diagnoses include other early-onset epileptic encephalopathies and prolonged febrile seizure episodes. First-line management includes the use of drugs such as valproate, clobazam, and stiripentol. Avoidance of sodium channel blocking agents (e.g., carbamazepine, phenytoin, lamotrigine) is vital. For children and adolescents, treatment is tailored to reduce seizure frequency and improve quality of life. In pregnant or lactating patients with Dravet syndrome, medication regimens must be reviewed carefully; drugs like valproate are teratogenic and alternative medications with a better safety profile should be considered in consultation with neurology and obstetrics specialists. Option A states that carbamazepine worsens seizures in Dravet syndrome, which is correct given the adverse effects of sodium channel blockers in this condition. Other options are not provided. 1. Dravet syndrome often starts with febrile seizures in infancy and evolves into multiple seizure types. 2. Avoid sodium channel blockers in patients with suspected or confirmed Dravet syndrome. 3. Early genetic testing can aid in accurate diagnosis and management. Recent guidelines emphasize the avoidance of sodium channel blockers and recommend using a combination of valproate, clobazam, and stiripentol. Ongoing research is focused on newer agents and potential gene therapies that may modify disease outcomes.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "7 years old boy playing PlayStation all night, the parents notice facial twitching with right arm speaking? the patient cannot speak during the seizure, post ictal the patient complaining of the right UL numbness, Dx:",
    "option_a": "Landau Kleffner syndrome",
    "option_b": "Centotemporal epilepsy",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "The clinical scenario describes a 7-year-old boy with focal motor seizures characterized by facial twitching, right arm involvement, and an inability to speak during the event, with postictal right upper limb numbness (a form of Todd's paralysis). This description is most consistent with benign childhood epilepsy with centrotemporal spikes, commonly known as centrotemporal (rolandic) epilepsy. Benign rolandic epilepsy originates from the perirolandic region (the area around the central sulcus). The transient abnormal electrical activity in this region leads to focal motor seizures affecting the face and upper extremities. Speech arrest can occur if the seizure activity spreads to or involves adjacent areas, particularly in the dominant hemisphere. Typical presentations include seizures often occurring during sleep or on awakening, with symptoms involving twitching or numbness of the orofacial region and one upper limb. The postictal period may include transient weakness (Todd's paralysis). In contrast, Landau-Kleffner syndrome is characterized primarily by language regression and acquired aphasia rather than focal motor signs. The diagnosis is based on clinical history and electroencephalogram (EEG) showing characteristic centrotemporal spikes. Differential diagnoses include Landau-Kleffner syndrome, which chiefly presents with language deficits, and other focal epilepsies. Careful EEG evaluation and clinical correlation help distinguish these conditions. Management is often conservative given the self-limiting nature of the condition. If treatment is indicated because of frequent or disruptive seizures, first-line medications include levetiracetam or lamotrigine. In cases where medication is required for a longer duration, the risk\u2013benefit profile should be discussed with parents. Although not directly applicable in children, in pregnant or lactating individuals with focal epilepsy, the medication regime should be adjusted to minimize fetal exposure while maintaining seizure control. Option B (Centotemporal epilepsy) is correct as it directly corresponds to benign rolandic epilepsy. Option A (Landau Kleffner syndrome) is incorrect because it primarily presents with language regression rather than focal motor seizures with postictal deficits. 1. Benign rolandic epilepsy typically presents in school-aged children and often resolves by adolescence. 2. Todd\u2019s paralysis (postictal weakness) can help confirm the focal nature of the seizure. 3. Sleep deprivation is a common seizure precipitant in children with epilepsy. Current guidelines support a conservative approach in benign rolandic epilepsy, with treatment offered primarily for seizures that impair quality of life. Recent studies emphasize the benign prognosis of this condition, and the use of EEG for diagnosis remains the standard.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "what is the definition of the ictal speech?",
    "option_a": "intelligible talking localizing to the dominant hemisphere.",
    "option_b": "Un-intelligible talking localizing to the dominant hemisphere.",
    "option_c": "intelligible talking localizing to the non-dominant hemisphere.",
    "option_d": "Un-intelligible talking localizing to the non-dominant hemisphere.",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "Ictal speech refers to the phenomenon where patients are able to produce intelligible speech during a seizure. This finding is used in the lateralization of seizure onset. Typically, intact, intelligible ictal speech suggests that the language areas (usually located in the dominant hemisphere) are spared, thereby localizing the seizure onset to the non-dominant hemisphere. During focal seizures that involve the language network, patients often exhibit aphasia or impaired speech. However, when seizure activity is confined to non-dominant hemisphere regions, particularly those not responsible for language production, the patient may produce intelligible speech during the ictal phase. This distinction aids in the localization process during presurgical evaluations. The presence of intelligible ictal speech can be a localizing sign in patients being evaluated for epilepsy surgery. Patients who maintain fluent speech during seizures are likely to have their epileptogenic focus in the non-dominant (typically right) hemisphere, whereas impaired speech suggests dominant hemisphere involvement. The evaluation of ictal speech involves detailed seizure semiology observation during video-EEG monitoring. Differentiation from postictal dysphasia or ictal stuttering is critical. Differential diagnoses include other ictal phenomena with speech disturbances, which require careful clinical and electrophysiological correlation. While the identification of ictal speech is primarily diagnostic and aids in localization rather than direct management, it plays a crucial role in surgical planning for drug-resistant epilepsy. In pregnant or lactating patients, non-invasive localization techniques (e.g., video-EEG monitoring and functional imaging) are favored to reduce risk. Treatment is directed at achieving optimal seizure control while preserving language function. Option C (intelligible talking localizing to the non-dominant hemisphere) is correct. Option A is incorrect because intelligible ictal speech is not typical when seizures involve language-dominant areas. Options B and D describe unintelligible talking, which does not fit the definition of ictal speech as used in this context. 1. Intelligible ictal speech is a useful localizing sign, often pointing to a seizure focus in the non-dominant hemisphere. 2. Careful observation during video-EEG monitoring can inform presurgical planning. 3. Preserved speech during seizures generally indicates sparing of the dominant language areas. Recent research using advanced imaging and EEG techniques reinforces the association between preserved, intelligible ictal speech and non-dominant hemisphere seizure onset. Updated guidelines in epilepsy surgery emphasize the importance of detailed ictal semiology, including speech analysis, to improve localization and surgical outcomes.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "Hypsarrhythmia with TS, what is the treatment:",
    "option_a": "ACTH",
    "option_b": "Corticosteroid",
    "option_c": "Vigabatrin",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "Infantile spasms are a type of epileptic encephalopathy characterized by the sudden onset of brief seizures accompanied by an abnormal chaotic background on EEG called hypsarrhythmia. In patients with tuberous sclerosis (TS), infantile spasms are common and require urgent treatment to prevent further developmental delay. In TS, cortical tubers and other brain lesions lead to aberrant neuronal networks that produce the disorganized electrical activity seen on EEG. Vigabatrin acts by inhibiting GABA transaminase, thereby increasing levels of GABA, the primary inhibitory neurotransmitter. This helps stabilize the neuronal hyperexcitability underlying infantile spasms, particularly in the context of structural abnormalities such as those seen in TS. Infantile spasms typically present within the first year of life with clusters of brief spasms, often upon waking. In the context of TS, these spasms are associated with the classic EEG pattern of hypsarrhythmia. Early intervention is crucial, as these seizures can have a significant impact on neurodevelopment if not rapidly controlled. Diagnosis is made primarily through clinical presentation supported by an EEG showing hypsarrhythmia. Differential diagnoses include other causes of infantile epileptic encephalopathy (such as symptomatic West syndrome due to metabolic disorders or brain malformations). Neuroimaging aids in diagnosing TS by revealing cortical tubers and subependymal nodules. According to current guidelines, vigabatrin is the first-line treatment for infantile spasms associated with tuberous sclerosis. ACTH and corticosteroids are also used in idiopathic infantile spasms but are less effective in TS. When treating infants, careful monitoring for vigabatrin-associated retinal toxicity is essential. In situations involving pregnancy or lactation, while vigabatrin is not routinely used in these populations, any treatment decisions must balance the benefits and potential risks using available safety data and guidelines. Option A (ACTH) and Option B (corticosteroid) are valid first-line options for infantile spasms in general; however, in the subgroup with tuberous sclerosis, vigabatrin has shown superior efficacy. Option C (vigabatrin) is thus the correct choice. Option D is not provided. 1) In TS-associated infantile spasms, vigabatrin is preferred over hormonal therapy. 2) Early treatment can significantly improve developmental outcomes. 3) Always monitor for potential visual field defects with vigabatrin use. Recent studies and consensus guidelines (including those from the International League Against Epilepsy) continue to support vigabatrin as the preferred initial therapy in tuberous sclerosis-related infantile spasms due to its efficacy in controlling spasms and improving EEG abnormalities.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "JME, what is the channel involved:",
    "option_a": "Na",
    "option_b": "Ca",
    "option_c": "Cl",
    "option_d": "K",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Juvenile Myoclonic Epilepsy (JME) is an idiopathic generalized epilepsy syndrome that typically begins in adolescence. It is characterized by myoclonic jerks, generalized tonic-clonic seizures, and sometimes absence seizures. JME is considered a channelopathy with genetic predispositions. Among the various ion channels implicated, voltage-gated calcium channels (and specifically certain subunits like those encoded by CACNB4) have been associated with the condition. These channels are critical in regulating neuronal excitability and the rhythmic firing in thalamocortical circuits, which can lead to generalized epileptic discharges. Patients with JME often experience myoclonic jerks soon after waking, and many also suffer from generalized tonic-clonic seizures. EEG typically demonstrates generalized polyspike and wave discharges. The underlying ion channel dysfunction contributes to the hyperexcitability seen in these patients. Diagnosis is primarily clinical, supported by characteristic EEG findings. Differential diagnoses include other idiopathic generalized epilepsies like childhood absence epilepsy or other myoclonic epilepsies. Genetic studies, although available, are not routinely used in clinical practice for diagnosis. First-line management often involves antiepileptic drugs such as valproic acid, levetiracetam, or sometimes lamotrigine (though caution is needed as lamotrigine may worsen myoclonic jerks in some cases). In pregnant patients, valproate is generally avoided due to high teratogenicity; levetiracetam is considered a safer option. Lactation considerations similarly favor agents with a better safety profile for the infant. Option A (Na): Sodium channels are involved in many epilepsies but are not the primary channel implicated in JME. Option B (Ca): Calcium channels, particularly components like the beta subunit, have been implicated in the pathogenesis of JME, making this the correct answer. Option C (Cl): Chloride channels are not typically associated with JME. Option D (K): While potassium channels are important in neuronal excitability, they are not the main channel implicated in JME pathophysiology. 1) JME typically presents in adolescence with morning myoclonic jerks accompanied by generalized seizures. 2) Many patients require lifelong therapy, and drug choice should be tailored especially in women of childbearing potential. 3) Recognizing the genetic and channelopathy aspects of JME helps in understanding its treatment nuances. Ongoing genetic research continues to shed light on the multiple ion channels involved in JME. Recent studies support the role of voltage-gated calcium channel subunits, reaffirming calcium channels\u2019 involvement in the disease's pathogenesis.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "24 years old female patient presented with fever & symptoms of meningitis, with psychiatry manifestation. HSV PCR +ve, MRI there was temporal lobe petechial hg with encephalomalacia she received treatment & improved, then she had seizure, what is the cause of the seizure.",
    "option_a": "expected sequale of HSV.",
    "option_b": "Anti NMDA",
    "option_c": "Recurrent HSV.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Herpes Simplex Virus (HSV) encephalitis is a severe infection of the brain, often affecting the temporal lobes. A common sequela of HSV encephalitis is the development of epilepsy due to structural and gliotic changes in the affected regions. HSV encephalitis typically causes necrosis and inflammation, especially in the temporal lobes. The resulting encephalomalacia and scar tissue create an epileptogenic focus that predisposes patients to develop seizures as a delayed complication. Although autoimmune phenomena (such as anti-NMDA receptor encephalitis) can follow HSV, the most common cause of post-HSV seizures is the expected sequela from the tissue damage. A patient who has been treated successfully for HSV encephalitis may later develop seizures due to the permanent scarring and consequent abnormal electrical activity in the temporal lobe. This is considered a common long-term complication. While anti-NMDA receptor encephalitis is an important differential, it often presents with a constellation of prominent psychiatric symptoms and occurs in a biphasic pattern after the infection. Evaluation includes repeated imaging (MRI) showing residual changes such as encephalomalacia, EEG to document epileptiform discharges, and possibly CSF analysis. Differential diagnoses include recurrent HSV encephalitis (which would typically show active inflammation and positive PCR) and post-infectious autoimmune encephalitis (where antibody testing, especially for NMDA receptors, would be informative). Management of post-HSV seizures involves standard antiepileptic treatment. First-line drugs include levetiracetam, lamotrigine, or valproate, with the choice guided by the patient\u2019s profile. In women of childbearing age or during pregnancy and lactation, drugs with lower teratogenicity (e.g., lamotrigine or levetiracetam) are preferred, with folic acid supplementation recommended. Option A (expected sequela of HSV) is correct because the seizure is most likely due to the structural damage and gliosis following HSV encephalitis. Option B (Anti NMDA) describes a post-infectious autoimmune phenomenon, which while recognized, is less common and usually accompanied by distinct clinical features. Option C (Recurrent HSV) would generally present with renewed signs of encephalitis and a positive PCR. Option D is not provided. 1) Temporal lobe scarring following HSV encephalitis is a common cause of subsequent seizures. 2) Always differentiate between a structural sequela and autoimmune phenomena when evaluating post-HSV seizures. 3) Recurrent HSV encephalitis would typically present with re-emerging infectious signs and a positive CSF PCR. Recent clinical studies and reviews underscore that postencephalitic epilepsy is a well-recognized complication of HSV encephalitis. While cases of post-HSV autoimmune encephalitis (e.g., anti-NMDA receptor encephalitis) have been reported, the majority of seizures following HSV are due to irreversible structural damage.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "case of status epilepticus when the compensatory mechanism will fail:",
    "option_a": "5 min.",
    "option_b": "10 min.",
    "option_c": "30-60 min",
    "option_d": "15 min",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Status epilepticus is defined as a seizure that is abnormally prolonged or repetitive without full recovery between episodes. A key pathophysiological concept is that the brain\u2019s compensatory inhibitory mechanisms eventually fail, leading to a self-sustaining seizure. During prolonged seizures, the normal inhibitory systems, primarily mediated by GABA receptors, become less responsive due to receptor internalization and alterations in neurotransmitter dynamics. While an initial seizure may be self-limited by these compensatory mechanisms, prolonged activity (typically 30-60 minutes) results in their failure. This transition marks the onset of status epilepticus where the seizure becomes refractory\u2014that is, less responsive to standard therapy. Clinically, status epilepticus is an emergency because the prolonged seizure activity can lead to neuronal injury, systemic complications, and increased morbidity and mortality. The failure of compensatory mechanisms explains why early intervention\u2014often within minutes\u2014is critical. Diagnosis is usually clinical, based on the duration of seizure activity (commonly defined as lasting >5 minutes). EEG studies may help in nonconvulsive status epilepticus. Differential diagnoses include psychogenic non-epileptic seizures and other causes of altered mental status with convulsive activity. Management begins with administration of benzodiazepines (e.g., lorazepam) as a first-line therapy if a seizure lasts more than 5 minutes. If seizures persist, second-line agents like fosphenytoin, levetiracetam, or valproate are administered. In pregnant or lactating patients, careful selection of antiepileptic drugs is vital to minimize fetal exposure\u2014levetiracetam is often preferred due to its favorable safety profile, while benzodiazepines are used with caution, balancing the risks of ongoing seizures with potential neonatal effects. Option A (5 min) represents the typical threshold to define status epilepticus but does not represent the time when compensatory mechanisms fail. Option B (10 min) and Option D (15 min) are too early for the complete failure of these mechanisms. Option C (30-60 min) is correct because it corresponds to the time frame in which GABA receptor internalization and other neurochemical changes render the seizure self-sustaining. 1) Early treatment of status epilepticus is crucial to prevent irreversible neuronal damage. 2) The diminishing effectiveness of GABAergic mechanisms after about 30 minutes contributes significantly to treatment resistance. 3) Status epilepticus requires rapid, tiered escalation of therapy. Contemporary guidelines emphasize the importance of early intervention to prevent the pathophysiological changes that occur after 30 minutes of seizure activity. Recent research has provided further insight into receptor trafficking during prolonged seizures, reinforcing the need for rapid treatment escalation to improve outcomes.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  }
]